AMGA is stressing that regulatory relief is urgently needed to prevent broader health care system disruptions, considering the recent Medicaid funding cuts put forth in the One Big Beautiful Bill.
Alexandria, Virginia — In a new letter addressed to HHS Secretary Robert F. Kennedy, Jr, the American Medical Group Association (AMGA) is urging the agency to modernize Medicare regulations, warning that outdated rules and processes threaten health care access and provider sustainability—and could potentially compound the damage portended by the passage of the One Big Beautiful Bill Act.
As it did last month to CMS' Medicare Regulatory Relief request for information (RFI), AMGA has responded to HHS’ “Ensuring Lawful Regulation and Unleashing Innovation to Make American Healthy Again" RFI, highlighting key areas of concern:
Jerry Penso, MD, MBA | Image Credit: AMGA
AMGA stressed that regulatory relief is urgently needed to prevent broader health care system disruptions.
“The combination of rising administrative burdens and historic federal funding cuts is a recipe for reduced access to care,” said Jerry Penso, MD, MBA, AMGA president and CEO. “We need a regulatory system that supports—not impedes—clinicians' ability to care for their patients.”
For a more in-depth look at this latest RFI and to read a detailed account of AMGA's response to HHS, click here to read the association's letter.
AI in Health Care: Balancing Governance, Innovation, and Trust
September 2nd 2025In this conversation with Reuben Daniel, associate vice president of artificial intelligence at UPMC Health Plan, we dive into how UPMC Health Plan builds trust with providers and members, discuss challenges of scaling AI effectively, and hear about concrete examples of AI's positive impact.
Listen
Stagnation in Reimbursement Keeps Biomedical Innovation From Reaching All Patients, COA Panel Says
September 9th 2025Panelists at the Community Oncology Alliance Payer Exchange Summit discuss the urgent need for innovative reimbursement models in cancer care to match advancements in biomedical technology and drug discovery.
Read More